loader
Please Wait
Applying Filters...

Evonik Evonik

X

List of Certificates of Suitability (CEPs) for r1_cep_2006_216___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Boehringer Ingelheim Pharma GmbH & Co. KG Ingelheim Am Rhein DE (1)

filter

01 Hyoscine (1)

filter

01 Germany (1)

filter

01 Withdrawn by Holder (1)

URL Supplier Web Content
R1-CEP 2006-216 - Rev 00
Withdrawn by Holder
Chemical
2014-06-05
2018-03-01
2167
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for Certificates of Suitability (CEPs) for R1-CEP 2006-216 - Rev 00 of Boehringer Ingelheim Pharma Gmbh & Co. Kg Ingelheim Am Rhein De

Looking for Certificates of Suitability (CEPs) for R1-CEP 2006-216 - Rev 00 of Boehringer Ingelheim Pharma Gmbh & Co. Kg Ingelheim Am Rhein De 1

20

Boehringer Ingelheim Pharma Gmbh & Co. Kg Ingelheim Am Rhein De, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their significant offerings is Hyoscine, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2006-216 - Rev 00

This Chemical Type CEP, issued on June 05, 2014, remains in force until March 01, 2018, ensuring its reliability within the pharmaceutical industry.

Substance Number 2167 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY